Design of improved polymerase chain reaction (PCR) method containing internal positive control (IPC) for molecular detection of Yersinia pestis  by Eini, F. et al.
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well-deﬁned intradermal reaction size were reviewed.
Results: We identiﬁed 358 medical records: 170(47%) of
L and 188(53%) of ML. Patients from both groups acquired
he infection in Madre de Dios, Junin and Huanuco. Median
ge (IQR) of CL was 26 years (IQR:19—38) and 72% were
ale. Median age of ML patients was 30 years (IQR:21—75),
6% were male, and 99% had previous CL with 8 months
IQR:3—18) of active ulcerative lesion. ML patients reported
L 10 years ago (IQR:6—19): 40% received Pentavalent
ntimonials, 11% trivalent antimonials and 26% reported a
pontaneous cure. The diagnosis of ML was done by PCR (9%),
crapping (22%), culture (38%), and/or an adequate clinical
esponse (31%). MST was 15mm (IQR:10—18) in ML and 8mm
IQR:6-10) in CL. Using a MST diameter of 15mm as cut point
or the diagnosis of ML, we found a sensitivity of 52%, speci-
city of 93%, positive predictive value of 90% and a negative
redictive value of 63%.
Conclusion: Patients with lesions compatible with ML,
revious CL, and an MST>15mm, have a high likelihood of
L; therefore, we can use this approach for diagnosis in
owresources settings where physicians have limitations in
iagnosis and they need to provide a justiﬁed treatment.
oi:10.1016/j.ijid.2010.02.425
5.026
tudy of the efﬁcient treatment of the inﬂuenza (S-OIV,
/H1N1)
. Iwamura ∗, W. Nakanishi, C. Yamada, M. Shinogami
Tokyo Metropolitan Police Hospital, Tokyo, Japan
Background: Inﬂuenza, transmitted by contact with
nfected individuals, presents with fever, arthralgia, nasal
ischarge, etc. Although inﬂuenza kits are often used for
he diagnosis of inﬂuenza, the reported percentage of S-
IV, A/H1N1 inﬂuenza cases in which the kit is useful for
he diagnosis varies from 50% to 90%. This rate probably
aries depending on the interval from symptom appearance
o the test, and also the presenting symptoms. We recently
nvestigated the efﬁcient treatment of the inﬂuenza (S-OIV,
/H1N1).
Methods: The inﬂuenza kit (Hanaco Medical Co., Ltd.)
as used for the diagnosis in 279 individuals presenting
ith inﬂuenza-like symptoms at the Tokyo Metropolitan
olice Hospital between August 1 and October 6, 2009. The
ymptoms, history of contact with infected individuals, and
nterval from symptom appearance to the test (0—12 hours,
2—24 hours, 24—48 hours, and over 48 hours) were ana-
yzed.
Results: Fever (over 38 ◦C) was seen in 18%, sore throat
n 26%, nasal discharge in 7% and arthralgia in 26% of all indi-
iduals testing positive with this kit. The positive rate did
ot differ signiﬁcantly depending on the interval from symp-
om appearance to the test (0—12 hours, 19.6%; 1—24 hours,
6.1%; 24—48 hours, 34.1%; over 48 hours, 34.1%). The
nﬂuenza positive rate was markedly high (83%) only in indi-
iduals having a positive history of contact.Conclusion: The diagnostic rate with the kit was less
han 50% even in individuals presenting with fever (the
ost characteristic symptom of inﬂuenza). Thus, a deﬁnitive
iagnosis of inﬂuenza may not be possible with a kit alone.
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he positive rate did not differ signiﬁcantly among different
ymptom groups, or depending on the interval from symptom
ppearance to the test. However, it was markedly high (83%)
n individuals with a positive history of contact. Patients hav-
ng a history of contact and presenting with inﬂuenza-like
ymptoms may be judged as having inﬂuenza without visiting
clinic and managed as homecare patients, by sending the
ntiviral agents to their homes. This approach would prevent
assive inﬂuenza outbreaks and also have socioeconomic
eneﬁts.
oi:10.1016/j.ijid.2010.02.426
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esign of improved polymerase chain reaction (PCR)
ethod containing internal positive control (IPC) for
olecular detection of Yersinia pestis
. Eini 1,∗, M. Fallah Raouﬁ1, M. Soleimani2, F. Azarifard1, E.
amshidiyan1, K. Majidzadeh2
Tasnim biotechnology research center, tehran, Iran,
slamic Republic of
Tasnim biotechnology research center, Tehran, Iran,
slamic Republic of
Background: Plague is one of the three epidemic dis-
ases still subject to the international health regulation and
otiﬁable to the WHO. Yersinia pestis, the causative agent
f plague in natural foci transmitted between rodent and
uman via wild rodent ﬂeas. So set up of suitable and sure
o surveillance and prevention of the disease is necessary.
he molecular methods such as polymerase chaine reaction
PCR) has allowed improvement of detection methods cur-
ently used in laboratories, although not all of thesemethods
nclude an Internal Positive Control (IPC) to monitor for false
egative results. Therefore we improved a uniplex and mul-
iplex PCR method with lower of limit of detection.
Methods: PCR reactions performed with primers which
argeted of the caf1 and pla genes located on the pFra and
Pst plasmids and the irp2 chromosomal gene located on the
pathogenicity island. For acquired different size of these
enes aditional primers were designed. In each gene two
arts required were ligated.The limit of detection deter-
ined by performing PCR reactions on serial dilutions of
lasmids containing the coresponding inserts.for evaluating
he speciﬁcity, PCR reactions were done for negative control
acteria.
Results: Assays were performed with genome of Y. pestis
hich produced three DNA fragments of the expected size
00, 400 and 520 base pairs (bp) corresponding to irp2, caf1
nd pla genes respectively. also, for IPC by the same primers
he different fragment of the expected size 150, 500 and 300
ase pairs (bp) corresponding to irp2, caf1 and pla genes
espectively were acquired. With The lower limit of detec-
ion was 370 copy numbers for caf1 gene and 21 for pla gene.
n PCR reactions for negative control bacteria detectable
ragments were not observed.
Conclusion: Our method clearly discriminated Y. pestis
NA bacteria which were tested. The rapidity, speciﬁcity
nd sensitivity of this procedure with the use of IPC to mon-
tor for false negative results can make this method suitable
or diagnosis and suggest that it can serve as a useful alter-
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native method for inoculation of laboratory animals or the
use of speciﬁc culture media for routine plaque surveillance
and outbreak investigations.
doi:10.1016/j.ijid.2010.02.427
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Development of a multiplex PCR system with application
of IPC (internal positive control) for detecting Bacillus
anthracis from environmental samples
M. Fallah Raouﬁ1,∗, F. Eini 1, F. Azarifard1, M. Soleimani2, E.
Jamshidiyan1, K. Majidzadeh2
1 Tasnim biotechnology research center, tehran, Iran,
Islamic Republic of
2 Tasnim biotechnology research center, Tehran, Iran,
Islamic Republic of
Background: Bacillus anthracis, the causative agent of
anthrax is a major concern of a dangerous and zoonotic
disease in medicine and veterinary medicine. The develop-
ment of rapid, sensitive and simple techniques to detect
B.anthracis in suspicious specimens is the important aim of
animals and subsequently public health. we described a mul-
tiplex PCR system with application of IPC (internal positive
control) for detecting virulence markers in B.anthracis.
Methods: In PCR assay pag and cap genes located on POX1
and POX2 plasmids were ampliﬁed by use of speciﬁc primers.
In order to control of reaction conditions, we used from PCR
products as a templet and designed IPC for pag and cap genes
that their length was shorter than product segments. After
cloning of PCR products, the sensitivity of the PCR test (limit
of detection) was also estimated. Control bacteria of deﬁned
species was conﬁrmed by ampliﬁcation of a fragment of the
16S rRNA gene by using two universal primers.
Results: In post-PCR stage 591 and 173 bp fragments
of DNA respectively to cap and pag genes recognized in
agarose gel. Sensitivity determination assays revealed that
this method can detect, 412 and 100 copies as LOD for cap
and pag gene respectively in samples.Nonetheless, bands on
the results with negative controls, these genes not present
in these deﬁned bacteria.
Conclusion: In this study, we desigined and optimized a
multiplex PCR assay for the detection and characterization
of B.anthracis from environmental samples. In addition to
we used from IPC to prevention of false negative results and
also to detect inhibitory effects of the sample matrix. The
PCR system described here can be proposed as rapid, safe,
diagnostic and conﬁdent method for detecting anthrax. The
sensitive and speciﬁc nature of this assay provides a valu-
able tool that can be used for analysing clinical and ﬁeld
samples and for improving our understanding of the ecology
and environmental prevalence of B.anthracis in natural foci
of disease.
doi:10.1016/j.ijid.2010.02.428
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B test-kit for rapid drug susceptibility testing ofM. tuber-
ulosis
. Domotenko ∗, M. Khramov
State Research Center for Applied Microbiology & Biotech-
ology, Obolensk, Russian Federation
Background: Drug resistant tuberculosis is an increasing
ublic health concern in many parts of the world, includ-
ng Russia. Traditional drug susceptibility testing is either
ime-consuming (21—28 days for the absolute concentra-
ion method) or expensive (automatic BACTEC systems). In
ontrast, TB test-kit developed at SRCAMB (in the frame of
TEP/DHHS projects #2 and 86) allows for reducing the time
f testing in 2.5 times, has low price and can be used in all
he bacteriological labs.
Methods: Drug susceptibility testing with TB test-kit is
ased on the ability of M. tuberculosis to reduce nitrates
o nitrites. The nitrites are detected with Griess reagent,
hich produces a color change. Sputum or suspension of M.
uberculosis strains inoculates into each a vial of the test-
it with syringe. Then vials of inoculated media incubate at
35± 2) ◦C. In 8—13 days of incubation resistant isolates of
. tuberculosis produce color changes in the vial with an
ppropriate drug. Susceptible isolates does not produce a
olor change.
Results: TB test - kit is a kit of ready-for-use nutrient
edia with drugs or without them and reagent for read-
ng results. The test-kit allows to determine susceptibility
f M. tuberculosis to isoniazid, rifampicin, streptomycin,
thambutol and to perform primary identiﬁcation of M.
uberculosis. The SRCAMB TB test-kit have been tested in
hree clinical laboratories in Russia in comparison with the
bsolute concentration method and the automated BACTEC
GIT 960 using about one thousand M. tuberculosis isolates.
ood agreement between the results of TB test kit and two
echniques was found. In 2008, the RF Ministry of Health
pproved the TB-test kit for production, sale and distribu-
ion at Russian Federation. TB test-kit is currently being
anufactured in SCRAMB and sold by small lots. The basic
onsumers of TB test - kit are mycobacteriological labora-
ories.
Conclusion: Performance of testing with the test-kit does
ot require special equipment and highly skilled personnel.
oi:10.1016/j.ijid.2010.02.429
5.030
roduction and standardization of Brucella national stan-
ard antiserum equivalent to OIEISS in Sudan
.F.E.M. Alawad1,∗, M.T. Musa2
Animal Resources Research corporation, Central
et.Research lab.(CVRL) -Soba, Khartoum, Sudan
Animal Resources Research Corporation, Khartoum, Sudan
Background: Brucellosis is a bacterial contagious zoonotic
isease caused by one of the ninth species of the genus
rucella, including the three proposed new species Brucella
eti, B.pinnipedis (Foster et al., 2002, 2007) and B.microti
Scholz et al., 2008a, 2008b). The serological tests were
